gms | German Medical Science

8th International Symposium on Age-related Macular Degeneration: Understanding pathogenetic mechanism – towards clinical translation

08. - 09.09.2023, Baden-Baden

Ural Eye and Medical study: prevalence and associated factor in AMD and specifically reticular pseudodrusen

Meeting Abstract

  • Jost B. Jonas - Mannheim/D
  • G.M. Kazakbaeva - Ufa/RUS
  • S. Panda-Jonas - Heidelberg/D
  • M.M. Bikbov - Ufa/RUS

8th International Symposium on Age-related Macular Degeneration: Understanding pathogenetic mechanism – towards clinical translation. Baden-Baden, 08.-09.09.2023. Düsseldorf: German Medical Science GMS Publishing House; 2023. Doc23amd04

doi: 10.3205/23amd04, urn:nbn:de:0183-23amd044

Veröffentlicht: 7. September 2023

© 2023 Jonas et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Purpose: To assess the prevalence of age-related macular degeneration (AMD) in a Russian population.

Methods: The population-based Ural Eye and Medical Study conducted in a rural and urban area in Bashkortostan/Russia included 5,899 participants aged 40+ years. AMD, defined according to the Beckman Initiative for Macular Research, was assessed on fundus photographs and optical coherence tomographic images of 4,932 (83.6%) participants.

Results: The prevalence of any AMD, early AMD, intermediate AMD, late AMD, geographic atrophy and neovascular AMD was 18.2% (95% confidence interval (CI):16.8,19.6), 11.6% (95%CI:10.4,12.8), 5.0% (95%CI:4.2,5.8), 1.6% (95%CI:1.1,2.0), 0.7% (95%CI:0.4,1.0) and 0.9% (95%CI:0.6,1.3) respectively, for individuals aged >55 years. Applying an age limit of 40+ years for the AMD definition, prevalence of any AMD, early AMD, intermediate AMD, late AMD, geographic atrophy and neovascular AMD was 14.1% (95%CI:13.1,15.1), 9.4% (95%CI:8.6,10.2), 3.8% (95%CI:3.2,4.3), 1.0% (95%CI:0.7,1.2), 0.4% (95%CI:0.2,0.6) and 0.5% (95%CI:0.3,0.7) respectively, for individuals aged 40+ years. Higher AMD prevalence was correlated with older age (odds ratio (OR):1.15;95%CI:1.13,1.16;P<0.001), rural region (OR:1.69;95%CI:1.32,2.17;P<0.001), lower diabetes prevalence (OR:0.56;95%CI:0.38,0.82;P=0.003), and shorter axial length (OR:0.89;95%CI:0.79,0.99; P=0.04). AMD prevalence was not significantly (all P≥0.20) correlated with any systemic parameter examined, except for lower prevalence of diabetes.

Conclusions: In this typical, ethnically mixed, urban and rural population from Russia, a higher AMD prevalence was mainly associated with older age, rural region of habitation, shorter axial length and lower prevalence of diabetes mellitus. The AMD prevalence was lower than in Europeans and higher than in East Asians.